Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...

The companies’ aim to unite their respective technologies to create an end-to-end workflow for precision medicine research in ...

In May 2023, the Human Pangenome Reference Consortium (HPRC) released the first draft of the human pangenome reference ...

Key market opportunities in the omics-based clinical trials sector include the rising adoption of personalized medicine, ...

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth include advancements in genetic engineering and genomics, an increasing ...

The global Life Science Instrumentation Market, valued at US$63.4 billion in 2025, is projected to advance at a resilient CAGR of 6.5% ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, ...